AMY2B

gene
On this page

Summary

AMY2B (amylase alpha 2B, HGNC:478) is a protein-coding gene on chromosome 1p21.1, encoding Alpha-amylase 2B (P19961).

Amylases are secreted proteins that hydrolyze 1,4-alpha-glucoside bonds in oligosaccharides and polysaccharides, and thus catalyze the first step in digestion of dietary starch and glycogen. The human genome has a cluster of several amylase genes that are expressed at high levels in either salivary gland or pancreas. This gene encodes an amylase isoenzyme produced by the pancreas.

Source: NCBI Gene 280 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 124 total
  • MANE Select transcript: NM_001387437

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:478
Approved symbolAMY2B
Nameamylase alpha 2B
Location1p21.1
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000240038
Ensembl biotypeprotein_coding
OMIM104660
Entrez280

Gene structure

Transcript identifiers

Ensembl transcripts: 8 — 4 protein_coding, 3 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay

ENST00000361355, ENST00000435302, ENST00000453959, ENST00000462971, ENST00000477657, ENST00000481821, ENST00000491397, ENST00000684275

RefSeq mRNA: 3 — MANE Select: NM_001387437 NM_001386109, NM_001387437, NM_020978

CCDS: CCDS782

Canonical transcript exons

ENST00000684275 — 10 exons

ExonStartEnd
ENSE00001642465103579311103579534
ENSE00001712096103577490103577608
ENSE00001757213103571589103571770
ENSE00003491719103577720103577845
ENSE00003492811103575441103575540
ENSE00003566157103574260103574393
ENSE00003569561103573708103573938
ENSE00003586191103572110103572256
ENSE00003587145103573063103573260
ENSE00003612859103575223103575345

Expression profiles

Bgee: expression breadth ubiquitous, 134 present calls, max score 99.81.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.3482 / max 343.4818, expressed in 54 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
43000.190451
43010.11234
42990.04556

Top tissues by expression

134 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
body of pancreasUBERON:000115099.81gold quality
right uterine tubeUBERON:000130298.46gold quality
cerebellar hemisphereUBERON:000224597.06gold quality
cerebellar cortexUBERON:000212997.02gold quality
right hemisphere of cerebellumUBERON:001489097.02gold quality
cerebellumUBERON:000203796.79gold quality
mucosa of stomachUBERON:000119996.29gold quality
left lobe of thyroid glandUBERON:000112096.04gold quality
tibial nerveUBERON:000132395.98gold quality
thyroid glandUBERON:000204695.93gold quality
right lobe of thyroid glandUBERON:000111995.83gold quality
apex of heartUBERON:000209895.76gold quality
calcaneal tendonUBERON:000370195.54gold quality
nucleus accumbensUBERON:000188295.40gold quality
gastrocnemiusUBERON:000138895.15gold quality
muscle of legUBERON:000138395.07gold quality
pancreasUBERON:000126495.01gold quality
caudate nucleusUBERON:000187394.77gold quality
putamenUBERON:000187494.59gold quality
cortex of kidneyUBERON:000122594.53gold quality
right frontal lobeUBERON:000281094.53gold quality
metanephros cortexUBERON:001053394.30gold quality
right atrium auricular regionUBERON:000663194.12gold quality
pituitary glandUBERON:000000794.11gold quality
left ovaryUBERON:000211994.03gold quality
right lungUBERON:000216794.03gold quality
subcutaneous adipose tissueUBERON:000219094.03gold quality
thoracic mammary glandUBERON:000520094.03gold quality
endocervixUBERON:000045893.97gold quality
left uterine tubeUBERON:000130393.91gold quality

Single-cell (SCXA)

Detected in 4 experiment(s), a significant marker in 3.

ExperimentMarker?Max mean expression
E-CURD-119yes39.86
E-GEOD-81547yes23.44
E-GEOD-100618no310.75
E-ANND-3no0.00

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 3)

  • It was concluded that the genetic variant determining starch metabolism influences the response to weight-loss dietary intervention. Overweight and obese individuals carrying the AMY1-AMY2 rs11185098 genotype associated with higher amylase activity may have greater loss of adiposity during low-calorie diet interventions. (PMID:28659346)
  • A significant link between serum amylase activity and ABO blood type in Chinese subjects. (PMID:30938472)
  • alpha-Amylase expressed in human small intestinal epithelial cells is essential for cell proliferation and differentiation. (PMID:31478242)

Cross-species orthologs

12 orthologs

OrganismSymbolGene ID
drosophila_melanogasterAmy-dFBGN0000078
drosophila_melanogasterAmy-pFBGN0000079
drosophila_melanogasterMal-A2FBGN0002569
drosophila_melanogasterMal-A3FBGN0002571
drosophila_melanogasterAmyrelFBGN0020506
drosophila_melanogasterMal-B1FBGN0032381
drosophila_melanogasterMal-B2FBGN0032382
drosophila_melanogasterMal-A4FBGN0033294
drosophila_melanogasterMal-A7FBGN0033296
drosophila_melanogasterMal-A8FBGN0033297
drosophila_melanogasterMal-A6FBGN0050360
caenorhabditis_elegansWBGENE00008220

Paralogs (7): GBE1 (ENSG00000114480), SLC3A1 (ENSG00000138079), SLC3A2 (ENSG00000168003), AMY1B (ENSG00000174876), AMY1C (ENSG00000187733), AMY1A (ENSG00000237763), AMY2A (ENSG00000243480)

Protein

Protein identifiers

Alpha-amylase 2BP19961 (reviewed: P19961)

Alternative names: 1,4-alpha-D-glucan glucanohydrolase 2B, Carcinoid alpha-amylase

All UniProt accessions (3): P19961, C9J2Z5, C9JWK7

UniProt curated annotations — full annotation on UniProt →

Subunit / interactions. Monomer.

Subcellular location. Secreted.

Cofactor. Binds 1 Ca(2+) ion per subunit. Binds 1 Cl(-) ion per subunit.

Similarity. Belongs to the glycosyl hydrolase 13 family.

Isoforms (2)

UniProt IDNamesCanonical?
P19961-11yes
P19961-22

RefSeq proteins (3): NP_001373038, NP_001374366, NP_066188 (=MANE)

Domains & families (InterPro)

IDNameType
IPR006046Alpha_amylaseFamily
IPR006047GH13_cat_domDomain
IPR006048A-amylase/branching_CDomain
IPR013780Glyco_hydro_bHomologous_superfamily
IPR017853GH_hydrolase_sfHomologous_superfamily
IPR031319A-amylase_CDomain

Pfam: PF00128, PF02806

UniProt features (20 total): binding site 7, disulfide bond 5, splice variant 2, active site 2, signal peptide 1, chain 1, site 1, modified residue 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P19961-F196.700.96

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Catalytic / active sites (3): 315 (transition state stabilizer); 212 (nucleophile); 248 (proton donor)

Ligand- & substrate-binding residues (7): 352; 115; 173; 182; 210; 216; 313

Post-translational modifications (1): 16

Disulfide bonds (5): 43–101, 85–130, 156–175, 393–399, 465–477

Function

Pathways and Gene Ontology

Reactome pathways

3 pathways

IDPathway
R-HSA-189085Digestion of dietary carbohydrate
R-HSA-8935690Digestion
R-HSA-8963743Digestion and absorption

MSigDB gene sets: 55 (showing top): MODULE_92, WANG_CLIM2_TARGETS_UP, MODULE_255, REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE, MODULE_317, NKX61_01, FREAC3_01, SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4, SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP, GOBP_CARBOHYDRATE_METABOLIC_PROCESS, TGANTCA_AP1_C, KEGG_STARCH_AND_SUCROSE_METABOLISM, MODULE_88, AACTTT_UNKNOWN, CUI_TCF21_TARGETS_2_DN

GO Biological Process (1): carbohydrate metabolic process (GO:0005975)

GO Molecular Function (8): alpha-amylase activity (GO:0004556), calcium ion binding (GO:0005509), chloride ion binding (GO:0031404), catalytic activity (GO:0003824), hydrolase activity (GO:0016787), hydrolase activity, acting on glycosyl bonds (GO:0016798), cation binding (GO:0043169), metal ion binding (GO:0046872)

GO Cellular Component (3): obsolete extracellular space (GO:0005615), extracellular exosome (GO:0070062), extracellular region (GO:0005576)

Reactome top-level categories

Rollup of top-2 pathways:

CategoryPathways
Digestion1
Digestion and absorption1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
primary metabolic process1
amylase activity1
metal ion binding1
anion binding1
molecular_function1
catalytic activity1
hydrolase activity1
ion binding1
cation binding1
extracellular vesicle1
cellular anatomical structure1

Protein interactions and networks

STRING

1728 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
AMY2BMGAMO43451986
AMY2BMGAM2Q2M2H8986
AMY2BSIP14410924
AMY2BGYG1P46976838
AMY2BCTRB1P17538835
AMY2BCTRB2Q6GPI1834
AMY2BGYG2O15488828
AMY2BHAO1Q9UJM8825
AMY2BALBP02768737
AMY2BPNLIPP16233729
AMY2BINSP01308692
AMY2BMANBAO00462686
AMY2BBCHEP06276676
AMY2BBPIP17213666
AMY2BATP1A1P05023653

IntAct

13 interactions, top by confidence:

ABTypeScore
DUSP4MYO1Cpsi-mi:“MI:0914”(association)0.350
DUSP4PSMD11psi-mi:“MI:0914”(association)0.350
Ppsi-mi:“MI:0914”(association)0.350
ORF10HSPA5psi-mi:“MI:0914”(association)0.350
ZBTB18CBR3psi-mi:“MI:0914”(association)0.350
AMY2AGYG2psi-mi:“MI:0914”(association)0.350
AMY1AGYG2psi-mi:“MI:0914”(association)0.350
AMY2AGYS1psi-mi:“MI:0914”(association)0.350
ZNF843AMY2Apsi-mi:“MI:0914”(association)0.350
AMY2BFOSpsi-mi:“MI:0915”(physical association)0.000
tkt1AMY2Bpsi-mi:“MI:0915”(physical association)0.000

BioGRID (9): AMY2B (Affinity Capture-MS), AMY2B (Affinity Capture-RNA), AMY2B (Affinity Capture-MS), AMY2B (Affinity Capture-MS), AMY2B (Affinity Capture-MS), AMY2B (Affinity Capture-MS), AMY2B (Affinity Capture-MS), AMY2B (Affinity Capture-MS), AMY2B (Affinity Capture-MS)

ESM2 similar proteins: H2N0D4, O18344, O18345, O18408, O18420, O18552, O76260, O76261, O76262, O76263, O76264, O76265, O76284, O76459, O77011, O77012, O77013, O77014, O77015, O77016, O77018, O77019, O77020, O77021, O77022, O97396, P00687, P00688, P00689, P00690, P04063, P04746, P04750, P08144, P09107, P0DTE7, P0DTE8, P0DUB6, P19961, P54215

Diamond homologs: A0A096XJN4, B0KZK1, H2N0D4, O18344, O18345, O18408, O18420, O18552, O76260, O76261, O76262, O76263, O76264, O76265, O76284, O76459, O77011, O77012, O77013, O77014, O77015, O77016, O77018, O77019, O77020, O77021, O77022, O97396, P00687, P00688, P00689, P00690, P04746, P08144, P08486, P09107, P09794, P0DTE7, P0DTE8, P0DUB6

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

124 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance98
Likely benign10
Benign2

Top pathogenic / likely-pathogenic (0)

SpliceAI

1840 predictions. Top by Δscore:

VariantEffectΔscore
1:103565899:T:TAacceptor_gain1.0000
1:103573062:GGTTC:Gacceptor_gain1.0000
1:103573257:TCAG:Tdonor_loss1.0000
1:103573258:CAG:Cdonor_loss1.0000
1:103573259:AGGTA:Adonor_loss1.0000
1:103573260:GGTAA:Gdonor_loss1.0000
1:103573261:GTAA:Gdonor_loss1.0000
1:103573895:G:GGdonor_gain1.0000
1:103573912:GGAA:Gdonor_gain1.0000
1:103573913:G:GTdonor_gain1.0000
1:103573913:G:Tdonor_gain1.0000
1:103573936:G:GTdonor_gain1.0000
1:103574256:CTAGG:Cacceptor_loss1.0000
1:103574257:TAG:Tacceptor_loss1.0000
1:103574258:A:Tacceptor_loss1.0000
1:103574259:G:GTacceptor_loss1.0000
1:103574392:AAGT:Adonor_loss1.0000
1:103574393:AGT:Adonor_loss1.0000
1:103574394:G:GGdonor_gain1.0000
1:103575338:GATGC:Gdonor_gain1.0000
1:103575342:C:Gdonor_gain1.0000
1:103575439:A:AGacceptor_gain1.0000
1:103575440:G:GGacceptor_gain1.0000
1:103575440:GGCT:Gacceptor_gain1.0000
1:103577483:A:AGacceptor_gain1.0000
1:103577717:TA:Tacceptor_loss1.0000
1:103577718:A:AGacceptor_gain1.0000
1:103577718:AG:Aacceptor_gain1.0000
1:103577718:AGGAA:Aacceptor_loss1.0000
1:103577719:G:GGacceptor_gain1.0000

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000077186 (1:103575013 GGTGT>G,GGT,GGTGTGT), RS1000260855 (1:103569589 G>C), RS1000381755 (1:103557418 A>G,T), RS1000515817 (1:103564242 A>C), RS1000549551 (1:103574810 T>C), RS1000589493 (1:103563958 A>G), RS1000653370 (1:103565508 A>G), RS1000837823 (1:103563614 C>G,T), RS1001017611 (1:103574066 C>G,T), RS1001151037 (1:103569675 G>A,C), RS1001227350 (1:103568732 T>A), RS1001246377 (1:103561216 G>A), RS1001341358 (1:103556525 G>A), RS1001395237 (1:103556266 A>G), RS1001435343 (1:103569828 G>A)

Disease associations

OMIM: gene MIM:104660 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST006585_2389Blood protein levels3.000000e-36

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

20 total (human), top 20 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyreneaffects methylation, decreases expression3
Tetrachlorodibenzodioxindecreases expression2
Cyclosporinedecreases expression, increases methylation2
Aflatoxin B1decreases expression, decreases methylation2
aristolochic acid Iincreases expression1
methylmercuric chloridedecreases expression1
triphenyl phosphateaffects expression1
sodium arseniteaffects expression1
jinfukangdecreases expression1
Resveratrolincreases expression, affects cotreatment1
Acetaminophenincreases expression1
Air Pollutantsincreases abundance, increases expression1
Arsenicaffects methylation1
Cisplatinincreases expression1
Estradiolincreases expression1
Plant Extractsaffects cotreatment, increases expression1
Tobacco Smoke Pollutiondecreases expression1
Valproic Aciddecreases expression1
Okadaic Aciddecreases expression1
Particulate Matterincreases abundance, increases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.